Nantahala Capital Management »

Adma Biologics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $20M 2.4M 8.37

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Peloton Interactive Cl A Com (PTON)
Hilton Grand Vacations (HGV)
Herbalife Com Shs (HLF)
Ban (TBBK)
Viatris Call Option (VTRS)
Edwards Lifesciences Put Option (EW)
Uniqure Nv SHS (QURE)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Bioventus Com Cl A (BVS)
Savara (SVRA)
Eton Pharmaceuticals (ETON)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Evolus (EOLS)
Abeona Therapeutics Com New (ABEO)

View all positions for Nantahala Capital Management

Top funds holding Adma Biologics

BlackRock
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
Rubric Capital Management
Capital Research Global Investors
First Trust Advisors
Geode Capital Management
Caligan Partners
D. E. Shaw & Co
Dimensional Fund Advisors
Goldman Sachs Group
Nuveen
Duquesne Family Office
Morgan Stanley

View all funds holding Adma Biologics